Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems
- PMID: 2843685
- PMCID: PMC253540
- DOI: 10.1128/JVI.62.10.3892-3895.1988
Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems
Abstract
The establishment of mammalian and procaryotic systems which express the Epstein-Barr virus (EBV) thymidine kinase (TK) has been reported previously (E. Littler, J. Zeuthen, A. A. McBride, E. Trøst-Sørensen, K. L. Powell, J. E. Walsh-Arrand, and J. R. Arrand, EMBO J. 5:1959-1966, 1986). The EBV TK activity expressed in both of these systems was characterized by in vitro assays and found to resemble that of the herpes simplex virus TK both in its broad range of nucleoside and nucleotide utilization and also in its ability to accept antiviral nucleoside analogs as substrates. Further results are presented which suggest that these in vitro systems may prove suitable for studying the potential anti-EBV activity of other candidate antiviral compounds.
Similar articles
-
The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.Antimicrob Agents Chemother. 1998 Nov;42(11):2923-31. doi: 10.1128/AAC.42.11.2923. Antimicrob Agents Chemother. 1998. PMID: 9797227 Free PMC article.
-
Characterization of an Epstein-Barr virus-induced thymidine kinase.J Virol. 1986 Mar;57(3):1105-12. doi: 10.1128/JVI.57.3.1105-1112.1986. J Virol. 1986. PMID: 3005613 Free PMC article.
-
Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells.Intervirology. 1981;15(1):43-8. doi: 10.1159/000149213. Intervirology. 1981. PMID: 6268568
-
Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.Curr Opin Oncol. 2001 Sep;13(5):360-7. doi: 10.1097/00001622-200109000-00008. Curr Opin Oncol. 2001. PMID: 11555713 Review.
-
Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.Am J Med. 1982 Jul 20;73(1A):18-26. doi: 10.1016/0002-9343(82)90057-2. Am J Med. 1982. PMID: 6285710 Review.
Cited by
-
The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.J Virol. 2010 May;84(9):4534-42. doi: 10.1128/JVI.02487-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181711 Free PMC article.
-
KSHV-TK is a tyrosine kinase that disrupts focal adhesions and induces Rho-mediated cell contraction.EMBO J. 2015 Feb 12;34(4):448-65. doi: 10.15252/embj.201490358. Epub 2014 Dec 3. EMBO J. 2015. PMID: 25471072 Free PMC article.
-
Identification and characterization of the conserved nucleoside-binding sites in the Epstein-Barr virus thymidine kinase.Biochem J. 2004 May 1;379(Pt 3):795-803. doi: 10.1042/BJ20031832. Biochem J. 2004. PMID: 14705959 Free PMC article.
-
The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.Antimicrob Agents Chemother. 1998 Nov;42(11):2923-31. doi: 10.1128/AAC.42.11.2923. Antimicrob Agents Chemother. 1998. PMID: 9797227 Free PMC article.
-
Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.Antimicrob Agents Chemother. 2014 Dec;58(12):7312-23. doi: 10.1128/AAC.03957-14. Epub 2014 Sep 29. Antimicrob Agents Chemother. 2014. PMID: 25267682 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources